Advanced

PSA Testing

Advanced

PSA Testing

New Prostate Screening Tests

There are four new tests which have been introduced to the UK market which are now available via GFCT. These tests use protein bio markers with the aim of providing a better indication of potential prostate cancer than PSA alone.

We are delighted to announce that we can now offer these four new tests.

We strongly recommend that you only consider having one of these tests after you have had a basic PSA test because if your PSA score is below 1.5, you are very unlikely to benefit from having one of these tests.

Two of the tests need to be ordered via a clinician, Stockholm3 and EpiSwitch.

If you require a clinician to order your test, please contact our office and we will introduce you to Dr Asif. He will carry out a consultation and if deemed necessary, will be able to order a test for you.

Alternatively, please ask your clinician to contact our office and we will assist with the ordering process.

Please find below full details of each test.

The Stockholm3 advanced PSA test is a comprehensive diagnostic tool for prostate cancer. It combines PSA levels with genetic and clinical data to improve accuracy in detecting and assessing prostate cancer, aiding in personalised treatment decisions.

The Proclarix® advanced PSA test uses a combination of traditional PSA levels and proprietary biomarkers to enhance prostate cancer detection. It provides a more accurate risk assessment, helping to identify patients who may need further diagnostic evaluation.

The Episwitch PSE test analyses gene expression patterns to assess the risk of prostate cancer. It uses advanced biomarkers to provide a more precise evaluation, helping differentiate between aggressive and indolent forms of the disease and guiding treatment decisions.

Temporarily Unavailable 

The Randox Advanced PSA Test goes beyond the limitations of a standard PSA test by integrating a Prostate Cancer Risk Score. This advanced test utilises a novel combination of biomarkers, including PSA, to more accurately assess an individual’s risk of developing prostate cancer.

The Prostatype score (P-Score) is a prognostic biomarker that integrates a three gene (IGFBP3, F3 and VGLL3) signature derived from prostate biopsy samples, with key clinical parameters, including prostate-specific antigen (PSA) levels, Gleason grade, and tumour stage at diagnosis. It may only be applied on biopsy from male individuals where a core needle biopsy procedure has confirmed the diagnosis of prostate cancer of Gleason score 6 or higher. The Prostatype result should always be used in combination with other clinical and patient specific information. The test is available through Pamela Trickett at Cambridge Clinical Laboratories and could be a useful addition to the decision making process for men on active surveillance.

How do I know if I need one of these tests?

We strongly recommend that you only consider having one of these tests after you have had a basic PSA test because if your PSA score is below 1.5, you are very unlikely to benefit from having one of these tests.

How can I get an advanced PSA test?

Two of the tests need to be ordered via a clinician, Stockholm3 and EpiSwitch.

If you require a clinician to order your test, please contact our office and we will introduce you to Dr Asif. He will carry out a consultation and if deemed necessary, will be able to order a test for you.

Alternatively, please ask your clinician to contact our office and we will assist with the ordering process.